06.15.2015
Improve Outcomes
$1,105,710.00
18 months
The Set-point Study
Funding to determine the effects of increasing the target glucose level of the insulin only and bi-hormonal (insulin and glucagon) Bionic Pancreas on mean glucose, hypoglycemia, and usage of glucagon and insulin.